You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SERD

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

Recruiting
  • Premenopausal Breast Cancer
  • +2 more
  • Taipei City, Taiwan
    Department of Oncology, National Taiwan University Hospital
Feb 7, 2023

Breast Cancer, Metastatic Cancer Trial in Shanghai (SHR7390, Famitinib, SHR3162)

Recruiting
  • Breast Cancer
  • Metastatic Cancer
  • Shanghai, Shanghai, China
    Cancer Hospital Affiliated to Fudan University
Jul 22, 2022

Breast Cancer, Metastatic Cancer Trial (SHR-1316, SHR6390, Nab paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Metastatic Cancer
  • (no location specified)
Jan 11, 2022

Breast Cancer Trial in Shanghai (SCR-6852, Palbociclib)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 18, 2022

Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)

Completed
  • Carcinoma, Ductal, Breast
  • +6 more
  • Beverly Hills, California
  • +14 more
Dec 14, 2022

Breast Cancer Trial in Worldwide (Amcenestrant (SAR439859), Letrozole)

Terminated
Has Results
  • Breast Cancer
  • Tucson, Arizona
  • +31 more
Jun 27, 2022

Breast Tumor Female Trial in Netherlands (CDK 4/6 inhibitor, Non-Steroidal Aromatase Inhibitor, Fulvestrant)

Active, not recruiting
  • Breast Neoplasm Female
  • CDK 4/6 inhibitor
  • +2 more
  • Alkmaar, Netherlands
  • +71 more
Apr 1, 2022

Resistance in ER+ Breast Cancer Patients:Translational Project

Recruiting
  • Breast Cancer
    • Aviano, Pordenone, Italy
    • +1 more
    Nov 8, 2023

    Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

    Recruiting
    • Metastatic Breast Cancer
    • Anchorage, Alaska
    • +58 more
    Jan 6, 2023

    GERD Trial in Milwaukee (Concurrent manometry/impedance/pH with video pharyngo-laryngoscopy, Slow and rapid intra-esophageal

    Recruiting
    • GERD
    • Concurrent manometry/impedance/pH with video pharyngo-laryngoscopy
    • Slow and rapid intra-esophageal infusion
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Jan 13, 2023

    Metastatic Breast Cancer Trial in Belgium, Netherlands (RAD1901)

    Completed
    • Metastatic Breast Cancer
    • Bruxelles, Belgium
    • +4 more
    Aug 16, 2022

    Puglia HCV Micro-elimination Program

    Completed
    • Hepatitis C
    • Adherence intervention research
    • San Giovanni Rotondo, Fg, Italy
      Alessandra Mangia
    Aug 3, 2021

    Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

    Not yet recruiting
    • Breast Cancer
    • Breast Cancer, Early-Onset
    • (no location specified)
    Jan 18, 2023

    Healthy Subjects Trial (Camizestrant, Itraconazole)

    Completed
    • Healthy Subjects
    • Harrow, United Kingdom
      Research Site
    Jan 5, 2023

    Breast Cancer Trial in Worldwide (LY3484356)

    Recruiting
    • Breast Cancer
    • Atlanta, Georgia
    • +19 more
    Aug 17, 2022

    Adult ADHD Trial in New York (Serdexmethylphenidate/dexmethylphenidate)

    Not yet recruiting
    • Adult Attention Deficit Hyperactivity Disorder
    • New York, New York
      NYU Langone Health
    Aug 18, 2023

    ER-Positive HER2-Negative Breast Cancer Trial in Worldwide (AZD9833, AZD9833 Placebo, Anastrozole)

    Recruiting
    • ER-Positive HER2-Negative Breast Cancer
    • Phoenix, Arizona
    • +215 more
    Aug 4, 2022

    Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

    Not yet recruiting
    • Advanced Breast Cancer
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Sep 12, 2022

    HER2-low in Metastatic Breast Cancer Patients

    Not yet recruiting
    • HER2-negative
      • (no location specified)
      Nov 9, 2023

      Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

      Not yet recruiting
      • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
      • (no location specified)
      Sep 26, 2023

      Advanced ER-Positive HER2-Negative Breast Cancer Trial in Worldwide (AZD9833, Fulvestrant)

      Active, not recruiting
      • Advanced ER-Positive HER2-Negative Breast Cancer
      • Birmingham, Alabama
      • +94 more
      Jan 31, 2023

      Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

      Not yet recruiting
      • Breast Cancer
      • (no location specified)
      Aug 12, 2022

      ER-Positive HER2-Negative Breast Cancer Trial in Worldwide (AZD9833, Anastrozole, Anastrozole )

      Recruiting
      • ER-Positive HER2-Negative Breast Cancer
      • Mobile, Alabama
      • +285 more
      Jan 28, 2022

      Breast Cancer Trial (Giredestrant, Abemaciclib, Inavolisib)

      Not yet recruiting
      • Breast Cancer
      • (no location specified)
      Feb 1, 2023